|
JANX Janux Therapeutics Inc 1817713 |
| Balance Sheet |
|
Current Assets
|
666,321,000 |
|
Assets
|
695,019,000 |
|
Current Liabilities
|
17,173,000 |
|
Liabilities
|
38,915,000 |
|
Equity
|
656,104,000 |
|
Shares Out
|
52,164,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-27,089,000 |
|
Investing Cash Flow
|
-291,947,000 |
| Market Analysis |
Market Cap
|
2,562,059,505 |
|
Price
|
40.72 |
|
BVPS
|
12.58 |
|
PB
|
3.26 |
|
EPS
|
-0.92 |
|
PS
|
1459.03 |
|
FCF
|
-319,036,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view JANX documents filed with the SEC.
JANX Filings
Clear
